digital health companies glp-1 management private obesity Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Virtual GLP-1 startups: Pill mills

In February 2026, the FDA publicly announced its intent to take action targeting mass-marketed, non-FDA-approved compounded GLP1 products, emphasizing that promotional claims implying equivalence to FDAapproved drugs can trigger enforcement risk

75g protein per 100g hit your protein target even when appetite is low

~4814 g/mol

Long-acting glucagon-like peptide (GLP)-1 analogs are currently available in treating diabetes with widely established safety and extensively evaluated efficacy

In this video, we explore the rising use of GLP-1 drugs like Ozempic and Wegovy, which were initially developed for managing conditions such as type 2 diabetes